Literature DB >> 306903

The association of HLA-B8 with visceral disease in systemic sclerosis.

P Hughes, K Gelsthorpe, R W Doughty, N R Rowell, F D Rosenthal, I B Sneddon.   

Abstract

Seventy-one patients with systemic sclerosis (SS) were typed for twenty-seven HLA alleles of the A and B loci, and the findings were related to both the extent of visceral disease and tests of cellular immune competence in a subgroup of fifty-two of these patients. Nineteen pa;ients with widespread visceral involvement and more rapidly progressive disease had an increased frequency of HLA-B8 (relative risk = 4.14; P less than 0.05) when compared to thirty-three less severely affected patients and 3000 controls. Patients with severe and progressive disease also had defective cell-mediated immunity with reductions in both the numbers of circulating thymus-dependent (T) lymphocytes and in the lymphocyte transformation response to phytohaemagglutinin. These findings suggest that a genetic factor, such as an abnormal immune response gene, may be involved in the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306903      PMCID: PMC1541243     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  HL-A antigens in myasthenia gravis.

Authors:  D Fritze; C Herrman; F Naeim; G S Smith; R L Walford
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

Review 2.  HL-A antigens and disease. Statistical and genetical considerations.

Authors:  A Svejgaard; C Jersild; L S Nielsen; W F Bodmer
Journal:  Tissue Antigens       Date:  1974

3.  Letter: HL-A and idiopathic Addison's disease.

Authors:  P Platz; L Ryder; L S Nielsen; A Svejgaard; M Thomsen; J Nerup; M Christy
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

4.  Histocompatibility antigens associated with adult coeliac disease.

Authors:  P L Stokes; P Asquith; G K Holmes; P Mackintosh; W T Cooke
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

5.  Leukocyte migration inhibition in progressive systemic sclerosis.

Authors:  P Hughes; S Holt; N R Rowell
Journal:  Br J Dermatol       Date:  1974-07       Impact factor: 9.302

6.  Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy.

Authors:  Z M Falchuk; G N Rogentine; W Strober
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

7.  Microtechnique for quantitative evaluation of in vitro lymphocyte transformation.

Authors:  U Junge; J Hoekstra; L Wolfe; F Deinhardt
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

8.  Association of Sjögren's syndrome with HLA-B8.

Authors:  K H Fye; P I Terasaki; H Moutsopoulos; T E Daniels; J P Michalski; N Talal
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

9.  Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).

Authors:  N F Rothfield; G P Rodnan
Journal:  Arthritis Rheum       Date:  1968-10

10.  HLA and pancreatic islet cell antibodies in diabetes.

Authors:  P J Morris; W J Irvine; R S Gray; L J Duncan; H Vaughan; F J McCallum; C J Campbell; J W Farquhar
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

View more
  21 in total

1.  European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

Authors:  G Valentini; A Della Rossa; S Bombardieri; W Bencivelli; A J Silman; S D'Angelo; M M Cerinic; J F Belch; C M Black; P Bruhlmann; L Czirják; A De Luca; A A Drosos; C Ferri; A Gabrielli; R Giacomelli; G Hayem; M Inanc; N J McHugh; H Nielsen; M Rosada; R Scorza; J Stork; A Sysa; F H van den Hoogen; P J Vlachoyiannopoulos
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 2.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Letter from Chicago: Temples, tubes, and plastic bags.

Authors:  G Dunea
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

4.  HLA-SD antigens in progressive systemic sclerosis.

Authors:  M Giordano; D Magrí; G Valentini; G Tirri; R De Biasi
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

5.  HLA antigens and scleroderma.

Authors:  M G Ercilla; F Arriaga; M R Gratacós; J Coll; V Lecha; J Vives; R Castillo
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.

Authors:  C G Kallenberg; J M Van der Voort-Beelen; J D'Amaro; T H The
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

7.  Small intestinal structure and passive permeability in systemic sclerosis.

Authors:  I Cobden; J Rothwell; A T Axon; M F Dixon; D J Lintott; N R Rowell
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

8.  Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

Authors:  C A Penning; J Cunningham; M A French; G Harrison; N R Rowell; P Hughes
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).

Authors:  C J Lynch; G Singh; T L Whiteside; G P Rodnan; T A Medsger; B S Rabin
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.